[1. ELLULU M., ABED Y., RAHMAT A., RANNEH Y., ALI F., Epidemiology of obesity in developing countries: challenges and prevention, Global Epidemic Obesity, 2014.10.7243/2052-5966-2-2]Search in Google Scholar
[2. WILBORN C., BECKHAM J., CAMPBELL B., HARVEY T., GALBREATH M., BOUNTY P.L. et al., Obesity: prevalence, theories, medical consequences, management, and research directions, J. Int. Soc. Sport. Nutr., 2005, 2(2):4–31.]Search in Google Scholar
[3. RACHMI C.N., LI M., BAUR L.A., Overweight and obesity in Indonesia: prevalence and risk factors – a literature review, Public Health, 2017, 147:20–29.10.1016/j.puhe.2017.02.00228404492]Search in Google Scholar
[4. ALBERTI K.G., ZIMMET P., SHAW J., Metabolic syndrome – a new world wide definition. A concencus state from the International Diabetes Federation, Diabet. Med., 2006, 23:469–480.10.1111/j.1464-5491.2006.01858.x16681555]Search in Google Scholar
[5. KARPE F., DICKMANN J.R., FRAYN K.N., Fatty acids, obesity, and insulin resistance: time for reevaluation, Diabetes, 2011; 60:2441–2447.]Search in Google Scholar
[6. MCARDLE M.A., FINUCANE O.M., CONNAUGHTON R.M., MCMORROW A.M., ROCHE H.M., Mechanisms of obesity-induced inflamation and insulin resistance: insights into emerging role of nutritional strategies, Front. Endocrinol., 2013, 4:52.10.3389/fendo.2013.00052365062023675368]Search in Google Scholar
[7. TCHERNOF A., DESPRES J.P., Pathophysiology of Human Visceral Obesity: An Update, Physiol. Rev., 2013, 93:359–404.10.1152/physrev.00033.201123303913]Search in Google Scholar
[8. PASQUALI R., VICENNATI V., GAMBINERI A., PAGOTTO U., Sex-Dependent Role of Glucocorticoids and Androgens in the Pathophysiology of Human Obesity, Int. J. Obes., 2008, 32(12):1764–1779.]Search in Google Scholar
[9. BIANCHI V.E., Metabolic Syndrome, Obesity Paradox and Testosterone Level, Endocrinol. Metab. Synd., 2015, 4(2):1–16.]Search in Google Scholar
[10. WANG C., JACKSON G., JONES T.H., MATSUMOTO A.M., NEHRA A., PERELMAN M.A. et al., Low Testosteron Associated with Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men with Type 2 Diabetes, Diabetes Care, 2011, 34:1669–1673.10.2337/dc10-2339312020921709300]Search in Google Scholar
[11. DI GUARDO F., CERANA M.C., D’URSO G., GENOVESE F., PALUMBO M., Male PCOS equivalent and nutritional restriction: are we stepping forward?, Med. Hypotheses, 2019, 126:1–3.10.1016/j.mehy.2019.03.00331010486]Search in Google Scholar
[12. WU F., TAJAR A., PYE S.R., SILMAN A.J., FINN J.D. et al., Hypothalamic – Pituitary – Testicular Axis Disruptions in Older Men are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study, J. Clin. Endocrinol. Metab., 2008, 93:2737–2745.10.1210/jc.2007-197218270261]Search in Google Scholar
[13. TREMELLEN K., PEARCE K., Nutrition, Fertility, and Human Reproductive Function, CRC Press, Florida, 2015:58–261.10.1201/b18190]Search in Google Scholar
[14. HOHL A., Testosterone from Basic to Clinical Aspects, Springer, Switzerland, 2017:149–159.10.1007/978-3-319-46086-4]Search in Google Scholar
[15. KELLY D.M., JONES T.H., Testosterone: A Metabolic Hormone in Health and Disease, J. Endocrinol., 2013, 217(3):R25–R45.10.1530/JOE-12-045523378050]Search in Google Scholar
[16. PITTELOUD N., MOOTHA V.K., DWYER A.A., HARDIN M., LEE H., ERIKSSON K.L. et al., Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men, Diabetes Care, 2005, 28:1636–1642.10.2337/diacare.28.7.163615983313]Search in Google Scholar
[17. CHEN X., LI X., HUANG H.Y., LI X., LIN J.F., Effect of Testosterone on Insulin Receptor Substrate-1 and Glucose Transporter 4 Expression in Cell Sensitive to Insulin, Zhonghua Yi Xue Za Zhi, 2006, 86:1474–1477.]Search in Google Scholar
[18. CONTRERAS P.H., SERRANO F.G., SALGADO A.M., VIGIL P., Insulin Sensitivity and Testiscular Function in a Cohort of Adult Males Suspected of Being Insulin-Resistant, Front. Med., 2018, 5:190.10.3389/fmed.2018.00190602860729998109]Search in Google Scholar
[19. CHENG J., HAN B., LI Q., XIA F., ZHAI H., WANG N. et al., Testosterone: Relationship with Metabolic Disorders, in Men – An Observational Study from SPECT-China, Int. J. Endocrinol., 2017, Volume 2017, Article ID4547658.10.1155/2017/4547658573317329333158]Search in Google Scholar
[20. LI C., FORD E.S., LI B., GILES W.H., LIU S., Association of Testosterone and Sex Hormone-Binding Globulin with Metabolic Syndrome and Insulin Resistance in Men, Diabetes Care, 2010, 33:1618–24.10.2337/dc09-1788289037020368409]Search in Google Scholar
[21. HANCHANG W., SEMPRASERT N., LIMJINDAPORN T., YENCHITSOMANUS P.T., KOOPTIWUT S., Testosterone Protects Against Glucotoxicity – Induced Apoptosis of Pancreatic β Cells (INS-1) and Male Mouse Pancreatic Islets, Endocrinology, 2003, Vol. 154(11):4058–67.10.1210/en.2013-135123970784]Search in Google Scholar